Global Celiac Diseases Drugs Market 2025-2029

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	212 Pages	TechNavio	March, 2025	INF19848645

Best Price Guarantee
Price	from $2,500
Length	212 Pages
Publisher	TechNavio
Published Date	March, 2025
SKU	INF19848645

Celiac Diseases Drugs Market 2025-2029

The celiac diseases drugs market is forecasted to grow by USD 1505 million during 2024-2029, accelerating at a CAGR of 23.6% during the forecast period. The report on the celiac diseases drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by higher consumption of gluten-containing food, increasing prevalence of celiac diseases, and government initiatives.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's celiac diseases drugs market is segmented as below:

By Therapy

First line treatment
Second-line treatment

By Route Of Administration

Oral
Parenteral

By Distribution Channel

Hospitals and specialty clinics
Specialty pharmacies
Retail pharmacies
Online platforms

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the inorganic growth strategies as one of the prime reasons driving the celiac diseases drugs market growth during the next few years. Also, increasing promising developments in celiac treatment and rising prevalence and diagnosis will lead to sizable demand in the market.

The report on the celiac diseases drugs market covers the following areas:

Celiac Diseases Drugs Market sizing
Celiac Diseases Drugs Market forecast
Celiac Diseases Drugs Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading celiac diseases drugs market vendors that include 9 Meters Biopharma Inc, Adaptive Biotechnologies Corp., Almirall SA, Amgen Inc., AMYRA Biotech AG, Artielle Immunotherapeutics Inc, Avaxia Biologics Inc., BioLineRx Ltd., Bristol Myers Squibb Co., Calypso Biotech BV, GlaxoSmithKline PLC, Glenmark Pharmaceuticals Ltd., ImmunogenX Inc., Johnson and Johnson Services Inc., Precigen Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Vactech Oy, and Zedira GmbH. Also, the celiac diseases drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Therapy; Executive Summary - Chart on Market Segmentation by Route of Administration; Executive Summary - Chart on Market Segmentation by Distribution Channel; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis: 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; 2.2 Criticality of inputs and Factors of differentiation; Overview on criticality of inputs and factors of differentiation; 2.3 Factors of disruption; Overview on factors of disruption; 2.4 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029
3 Market Landscape: 3.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 3.2 Market characteristics; Market characteristics analysis; 3.3 Value chain analysis; Value chain analysis
4 Market Sizing: 4.1 Market definition; Offerings of companies included in the market definition; 4.2 Market segment analysis; Market segments; 4.3 Market size 2024; 4.4 Market outlook: Forecast for 2024-2029; Chart on Global - Market size and forecast 2024-2029 ($ million); Data Table on Global - Market size and forecast 2024-2029 ($ million); Chart on Global Market: Year-over-year growth 2024-2029 (%); Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size: 5.1 Global Celiac Diseases Drugs Market 2019 - 2023; Historic Market Size - Data Table on Global Celiac Diseases Drugs Market 2019 - 2023 ($ million); 5.2 Therapy segment analysis 2019 - 2023; Historic Market Size - Therapy Segment 2019 - 2023 ($ million); 5.3 Route of Administration segment analysis 2019 - 2023; Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million); 5.4 Distribution Channel segment analysis 2019 - 2023; Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million); 5.5 Geography segment analysis 2019 - 2023; Historic Market Size - Geography Segment 2019 - 2023 ($ million); 5.6 Country segment analysis 2019 - 2023; Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis: 6.1 Impact of AI in global celiac diseases drugs market
7 Five Forces Analysis: 7.1 Five forces summary; Five forces analysis - Comparison between 2024 and 2029; 7.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2024 and 2029; 7.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2024 and 2029; 7.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2024 and 2029; 7.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2024 and 2029; 7.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2024 and 2029; 7.7 Market condition; Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Therapy: 8.1 Market segments; Chart on Therapy - Market share 2024-2029 (%); Data Table on Therapy - Market share 2024-2029 (%); 8.2 Comparison by Therapy; Chart on Comparison by Therapy; Data Table on Comparison by Therapy; 8.3 First line treatment - Market size and forecast 2024-2029; Chart on First line treatment - Market size and forecast 2024-2029 ($ million); Data Table on First line treatment - Market size and forecast 2024-2029 ($ million); Chart on First line treatment - Year-over-year growth 2024-2029 (%); Data Table on First line treatment - Year-over-year growth 2024-2029 (%); 8.4 Second-line treatment - Market size and forecast 2024-2029; Chart on Second-line treatment - Market size and forecast 2024-2029 ($ million); Data Table on Second-line treatment - Market size and forecast 2024-2029 ($ million); Chart on Second-line treatment - Year-over-year growth 2024-2029 (%); Data Table on Second-line treatment - Year-over-year growth 2024-2029 (%); 8.5 Market opportunity by Therapy; Market opportunity by Therapy ($ million); Data Table on Market opportunity by Therapy ($ million)
9 Market Segmentation by Route of Administration: 9.1 Market segments; Chart on Route of Administration - Market share 2024-2029 (%); Data Table on Route of Administration - Market share 2024-2029 (%); 9.2 Comparison by Route of Administration; Chart on Comparison by Route of Administration; Data Table on Comparison by Route of Administration; 9.3 Oral - Market size and forecast 2024-2029; Chart on Oral - Market size and forecast 2024-2029 ($ million); Data Table on Oral - Market size and forecast 2024-2029 ($ million); Chart on Oral - Year-over-year growth 2024-2029 (%); Data Table on Oral - Year-over-year growth 2024-2029 (%); 9.4 Parenteral - Market size and forecast 2024-2029; Chart on Parenteral - Market size and forecast 2024-2029 ($ million); Data Table on Parenteral - Market size and forecast 2024-2029 ($ million); Chart on Parenteral - Year-over-year growth 2024-2029 (%); Data Table on Parenteral - Year-over-year growth 2024-2029 (%); 9.5 Market opportunity by Route of Administration; Market opportunity by Route of Administration ($ million); Data Table on Market opportunity by Route of Administration ($ million)
10 Market Segmentation by Distribution Channel: 10.1 Market segments; Chart on Distribution Channel - Market share 2024-2029 (%); Data Table on Distribution Channel - Market share 2024-2029 (%); 10.2 Comparison by Distribution Channel; Chart on Comparison by Distribution Channel; Data Table on Comparison by Distribution Channel; 10.3 Hospitals and specialty clinics - Market size and forecast 2024-2029; Chart on Hospitals and specialty clinics - Market size and forecast 2024-2029 ($ million); Data Table on Hospitals and specialty clinics - Market size and forecast 2024-2029 ($ million); Chart on Hospitals and specialty clinics - Year-over-year growth 2024-2029 (%); Data Table on Hospitals and specialty clinics - Year-over-year growth 2024-2029 (%); 10.4 Specialty pharmacies - Market size and forecast 2024-2029; Chart on Specialty pharmacies - Market size and forecast 2024-2029 ($ million); Data Table on Specialty pharmacies - Market size and forecast 2024-2029 ($ million); Chart on Specialty pharmacies - Year-over-year growth 2024-2029 (%); Data Table on Specialty pharmacies - Year-over-year growth 2024-2029 (%); 10.5 Retail pharmacies - Market size and forecast 2024-2029; Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ million); Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ million); Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%); Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%); 10.6 Online platforms - Market size and forecast 2024-2029; Chart on Online platforms - Market size and forecast 2024-2029 ($ million); Data Table on Online platforms - Market size and forecast 2024-2029 ($ million); Chart on Online platforms - Year-over-year growth 2024-2029 (%); Data Table on Online platforms - Year-over-year growth 2024-2029 (%); 10.7 Market opportunity by Distribution Channel; Market opportunity by Distribution Channel ($ million); Data Table on Market opportunity by Distribution Channel ($ million)
11 Customer Landscape: 11.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape: 12.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2024-2029 (%); Data Table on Market share By Geographical Landscape 2024-2029 (%); 12.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 12.3 North America - Market size and forecast 2024-2029; Chart on North America - Market size and forecast 2024-2029 ($ million); Data Table on North America - Market size and forecast 2024-2029 ($ million); Chart on North America - Year-over-year growth 2024-2029 (%); Data Table on North America - Year-over-year growth 2024-2029 (%); 12.4 Europe - Market size and forecast 2024-2029; Chart on Europe - Market size and forecast 2024-2029 ($ million); Data Table on Europe - Market size and forecast 2024-2029 ($ million); Chart on Europe - Year-over-year growth 2024-2029 (%); Data Table on Europe - Year-over-year growth 2024-2029 (%); 12.5 Asia - Market size and forecast 2024-2029; Chart on Asia - Market size and forecast 2024-2029 ($ million); Data Table on Asia - Market size and forecast 2024-2029 ($ million); Chart on Asia - Year-over-year growth 2024-2029 (%); Data Table on Asia - Year-over-year growth 2024-2029 (%); 12.6 Rest of World (ROW) - Market size and forecast 2024-2029; Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); 12.7 US - Market size and forecast 2024-2029; Chart on US - Market size and forecast 2024-2029 ($ million); Data Table on US - Market size and forecast 2024-2029 ($ million); Chart on US - Year-over-year growth 2024-2029 (%); Data Table on US - Year-over-year growth 2024-2029 (%); 12.8 Canada - Market size and forecast 2024-2029; Chart on Canada - Market size and forecast 2024-2029 ($ million); Data Table on Canada - Market size and forecast 2024-2029 ($ million); Chart on Canada - Year-over-year growth 2024-2029 (%); Data Table on Canada - Year-over-year growth 2024-2029 (%); 12.9 UK - Market size and forecast 2024-2029; Chart on UK - Market size and forecast 2024-2029 ($ million); Data Table on UK - Market size and forecast 2024-2029 ($ million); Chart on UK - Year-over-year growth 2024-2029 (%); Data Table on UK - Year-over-year growth 2024-2029 (%); 12.10 Germany - Market size and forecast 2024-2029; Chart on Germany - Market size and forecast 2024-2029 ($ million); Data Table on Germany - Market size and forecast 2024-2029 ($ million); Chart on Germany - Year-over-year growth 2024-2029 (%); Data Table on Germany - Year-over-year growth 2024-2029 (%); 12.11 China - Market size and forecast 2024-2029; Chart on China - Market size and forecast 2024-2029 ($ million); Data Table on China - Market size and forecast 2024-2029 ($ million); Chart on China - Year-over-year growth 2024-2029 (%); Data Table on China - Year-over-year growth 2024-2029 (%); 12.12 France - Market size and forecast 2024-2029; Chart on France - Market size and forecast 2024-2029 ($ million); Data Table on France - Market size and forecast 2024-2029 ($ million); Chart on France - Year-over-year growth 2024-2029 (%); Data Table on France - Year-over-year growth 2024-2029 (%); 12.13 Italy - Market size and forecast 2024-2029; Chart on Italy - Market size and forecast 2024-2029 ($ million); Data Table on Italy - Market size and forecast 2024-2029 ($ million); Chart on Italy - Year-over-year growth 2024-2029 (%); Data Table on Italy - Year-over-year growth 2024-2029 (%); 12.14 Japan - Market size and forecast 2024-2029; Chart on Japan - Market size and forecast 2024-2029 ($ million); Data Table on Japan - Market size and forecast 2024-2029 ($ million); Chart on Japan - Year-over-year growth 2024-2029 (%); Data Table on Japan - Year-over-year growth 2024-2029 (%); 12.15 India - Market size and forecast 2024-2029; Chart on India - Market size and forecast 2024-2029 ($ million); Data Table on India - Market size and forecast 2024-2029 ($ million); Chart on India - Year-over-year growth 2024-2029 (%); Data Table on India - Year-over-year growth 2024-2029 (%); 12.16 The Netherlands - Market size and forecast 2024-2029; Chart on The Netherlands - Market size and forecast 2024-2029 ($ million); Data Table on The Netherlands - Market size and forecast 2024-2029 ($ million); Chart on The Netherlands - Year-over-year growth 2024-2029 (%); Data Table on The Netherlands - Year-over-year growth 2024-2029 (%); 12.17 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ million); Data Tables on Market opportunity By Geographical Landscape ($ million)
13 Drivers, Challenges, and Opportunity/Restraints: 13.1 Market drivers; 13.2 Market challenges; 13.3 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029; 13.4 Market opportunities/restraints
14 Competitive Landscape: 14.1 Overview; 14.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 14.3 Landscape disruption; Overview on factors of disruption; 14.4 Industry risks; Impact of key risks on business
15 Competitive Analysis: 15.1 Companies profiled; Companies covered; 15.2 Company ranking index; Company ranking index; 15.3 Market positioning of companies; Matrix on companies position and classification; 15.4 Adaptive Biotechnologies Corp.; Adaptive Biotechnologies Corp. - Overview; Adaptive Biotechnologies Corp. - Product / Service; Adaptive Biotechnologies Corp. - Key offerings; SWOT; 15.5 Almirall SA; Almirall SA - Overview; Almirall SA - Product / Service; Almirall SA - Key offerings; SWOT; 15.6 Amgen Inc.; Amgen Inc. - Overview; Amgen Inc. - Product / Service; Amgen Inc. - Key news; Amgen Inc. - Key offerings; SWOT; 15.7 AMYRA Biotech AG; AMYRA Biotech AG - Overview; AMYRA Biotech AG - Product / Service; AMYRA Biotech AG - Key offerings; SWOT; 15.8 BioLineRx Ltd.; BioLineRx Ltd. - Overview; BioLineRx Ltd. - Product / Service; BioLineRx Ltd. - Key offerings; SWOT; 15.9 Bristol Myers Squibb Co.; Bristol Myers Squibb Co. - Overview; Bristol Myers Squibb Co. - Product / Service; Bristol Myers Squibb Co. - Key news; Bristol Myers Squibb Co. - Key offerings; SWOT; 15.10 Calypso Biotech BV; Calypso Biotech BV - Overview; Calypso Biotech BV - Product / Service; Calypso Biotech BV - Key offerings; SWOT; 15.11 GlaxoSmithKline Plc; GlaxoSmithKline Plc - Overview; GlaxoSmithKline Plc - Business segments; GlaxoSmithKline Plc - Key news; GlaxoSmithKline Plc - Key offerings; GlaxoSmithKline Plc - Segment focus; SWOT; 15.12 Glenmark Pharmaceuticals Ltd.; Glenmark Pharmaceuticals Ltd. - Overview; Glenmark Pharmaceuticals Ltd. - Product / Service; Glenmark Pharmaceuticals Ltd. - Key offerings; SWOT; 15.13 ImmunogenX Inc.; ImmunogenX Inc. - Overview; ImmunogenX Inc. - Product / Service; ImmunogenX Inc. - Key offerings; SWOT; 15.14 Johnson and Johnson Services Inc.; Johnson and Johnson Services Inc. - Overview; Johnson and Johnson Services Inc. - Business segments; Johnson and Johnson Services Inc. - Key news; Johnson and Johnson Services Inc. - Key offerings; Johnson and Johnson Services Inc. - Segment focus; SWOT; 15.15 Precigen Inc.; Precigen Inc. - Overview; Precigen Inc. - Product / Service; Precigen Inc. - Key offerings; SWOT; 15.16 Sanofi SA; Sanofi SA - Overview; Sanofi SA - Business segments; Sanofi SA - Key news; Sanofi SA - Key offerings; Sanofi SA - Segment focus; SWOT; 15.17 Takeda Pharmaceutical Co. Ltd.; Takeda Pharmaceutical Co. Ltd. - Overview; Takeda Pharmaceutical Co. Ltd. - Product / Service; Takeda Pharmaceutical Co. Ltd. - Key news; Takeda Pharmaceutical Co. Ltd. - Key offerings; SWOT; 15.18 Teva Pharmaceutical Industries Ltd.; Teva Pharmaceutical Industries Ltd. - Overview; Teva Pharmaceutical Industries Ltd. - Business segments; Teva Pharmaceutical Industries Ltd. - Key news; Teva Pharmaceutical Industries Ltd. - Key offerings; Teva Pharmaceutical Industries Ltd. - Segment focus; SWOT
16 Appendix: 16.1 Scope of the report; 16.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 16.3 Currency conversion rates for US$; Currency conversion rates for US$; 16.4 Research methodology; Research methodology; 16.5 Data procurement; Information sources; 16.6 Data validation; Data validation; 16.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 16.8 Data synthesis; Data synthesis; 16.9 360 degree market analysis; 360 degree market analysis; 16.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Therapy; Exhibits6: Executive Summary - Chart on Market Segmentation by Route of Administration; Exhibits7: Executive Summary - Chart on Market Segmentation by Distribution Channel; Exhibits8: Executive Summary - Chart on Incremental Growth; Exhibits9: Executive Summary - Data Table on Incremental Growth; Exhibits10: Executive Summary - Chart on Company Market Positioning; Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits12: Overview on criticality of inputs and factors of differentiation; Exhibits13: Overview on factors of disruption; Exhibits14: Impact of drivers and challenges in 2024 and 2029; Exhibits15: Parent Market; Exhibits16: Data Table on - Parent Market; Exhibits17: Market characteristics analysis; Exhibits18: Value chain analysis; Exhibits19: Offerings of companies included in the market definition; Exhibits20: Market segments; Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ million); Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ million); Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%); Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%); Exhibits25: Historic Market Size - Data Table on Global Celiac Diseases Drugs Market 2019 - 2023 ($ million); Exhibits26: Historic Market Size - Therapy Segment 2019 - 2023 ($ million); Exhibits27: Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million); Exhibits28: Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million); Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ million); Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ million); Exhibits31: Five forces analysis - Comparison between 2024 and 2029; Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029; Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029; Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029; Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029; Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029; Exhibits37: Chart on Market condition - Five forces 2024 and 2029; Exhibits38: Chart on Therapy - Market share 2024-2029 (%); Exhibits39: Data Table on Therapy - Market share 2024-2029 (%); Exhibits40: Chart on Comparison by Therapy; Exhibits41: Data Table on Comparison by Therapy; Exhibits42: Chart on First line treatment - Market size and forecast 2024-2029 ($ million); Exhibits43: Data Table on First line treatment - Market size and forecast 2024-2029 ($ million); Exhibits44: Chart on First line treatment - Year-over-year growth 2024-2029 (%); Exhibits45: Data Table on First line treatment - Year-over-year growth 2024-2029 (%); Exhibits46: Chart on Second-line treatment - Market size and forecast 2024-2029 ($ million); Exhibits47: Data Table on Second-line treatment - Market size and forecast 2024-2029 ($ million); Exhibits48: Chart on Second-line treatment - Year-over-year growth 2024-2029 (%); Exhibits49: Data Table on Second-line treatment - Year-over-year growth 2024-2029 (%); Exhibits50: Market opportunity by Therapy ($ million); Exhibits51: Data Table on Market opportunity by Therapy ($ million); Exhibits52: Chart on Route of Administration - Market share 2024-2029 (%); Exhibits53: Data Table on Route of Administration - Market share 2024-2029 (%); Exhibits54: Chart on Comparison by Route of Administration; Exhibits55: Data Table on Comparison by Route of Administration; Exhibits56: Chart on Oral - Market size and forecast 2024-2029 ($ million); Exhibits57: Data Table on Oral - Market size and forecast 2024-2029 ($ million); Exhibits58: Chart on Oral - Year-over-year growth 2024-2029 (%); Exhibits59: Data Table on Oral - Year-over-year growth 2024-2029 (%); Exhibits60: Chart on Parenteral - Market size and forecast 2024-2029 ($ million); Exhibits61: Data Table on Parenteral - Market size and forecast 2024-2029 ($ million); Exhibits62: Chart on Parenteral - Year-over-year growth 2024-2029 (%); Exhibits63: Data Table on Parenteral - Year-over-year growth 2024-2029 (%); Exhibits64: Market opportunity by Route of Administration ($ million); Exhibits65: Data Table on Market opportunity by Route of Administration ($ million); Exhibits66: Chart on Distribution Channel - Market share 2024-2029 (%); Exhibits67: Data Table on Distribution Channel - Market share 2024-2029 (%); Exhibits68: Chart on Comparison by Distribution Channel; Exhibits69: Data Table on Comparison by Distribution Channel; Exhibits70: Chart on Hospitals and specialty clinics - Market size and forecast 2024-2029 ($ million); Exhibits71: Data Table on Hospitals and specialty clinics - Market size and forecast 2024-2029 ($ million); Exhibits72: Chart on Hospitals and specialty clinics - Year-over-year growth 2024-2029 (%); Exhibits73: Data Table on Hospitals and specialty clinics - Year-over-year growth 2024-2029 (%); Exhibits74: Chart on Specialty pharmacies - Market size and forecast 2024-2029 ($ million); Exhibits75: Data Table on Specialty pharmacies - Market size and forecast 2024-2029 ($ million); Exhibits76: Chart on Specialty pharmacies - Year-over-year growth 2024-2029 (%); Exhibits77: Data Table on Specialty pharmacies - Year-over-year growth 2024-2029 (%); Exhibits78: Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ million); Exhibits79: Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ million); Exhibits80: Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%); Exhibits81: Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%); Exhibits82: Chart on Online platforms - Market size and forecast 2024-2029 ($ million); Exhibits83: Data Table on Online platforms - Market size and forecast 2024-2029 ($ million); Exhibits84: Chart on Online platforms - Year-over-year growth 2024-2029 (%); Exhibits85: Data Table on Online platforms - Year-over-year growth 2024-2029 (%); Exhibits86: Market opportunity by Distribution Channel ($ million); Exhibits87: Data Table on Market opportunity by Distribution Channel ($ million); Exhibits88: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits89: Chart on Market share By Geographical Landscape 2024-2029 (%); Exhibits90: Data Table on Market share By Geographical Landscape 2024-2029 (%); Exhibits91: Chart on Geographic comparison; Exhibits92: Data Table on Geographic comparison; Exhibits93: Chart on North America - Market size and forecast 2024-2029 ($ million); Exhibits94: Data Table on North America - Market size and forecast 2024-2029 ($ million); Exhibits95: Chart on North America - Year-over-year growth 2024-2029 (%); Exhibits96: Data Table on North America - Year-over-year growth 2024-2029 (%); Exhibits97: Chart on Europe - Market size and forecast 2024-2029 ($ million); Exhibits98: Data Table on Europe - Market size and forecast 2024-2029 ($ million); Exhibits99: Chart on Europe - Year-over-year growth 2024-2029 (%); Exhibits100: Data Table on Europe - Year-over-year growth 2024-2029 (%); Exhibits101: Chart on Asia - Market size and forecast 2024-2029 ($ million); Exhibits102: Data Table on Asia - Market size and forecast 2024-2029 ($ million); Exhibits103: Chart on Asia - Year-over-year growth 2024-2029 (%); Exhibits104: Data Table on Asia - Year-over-year growth 2024-2029 (%); Exhibits105: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Exhibits106: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Exhibits107: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Exhibits108: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Exhibits109: Chart on US - Market size and forecast 2024-2029 ($ million); Exhibits110: Data Table on US - Market size and forecast 2024-2029 ($ million); Exhibits111: Chart on US - Year-over-year growth 2024-2029 (%); Exhibits112: Data Table on US - Year-over-year growth 2024-2029 (%); Exhibits113: Chart on Canada - Market size and forecast 2024-2029 ($ million); Exhibits114: Data Table on Canada - Market size and forecast 2024-2029 ($ million); Exhibits115: Chart on Canada - Year-over-year growth 2024-2029 (%); Exhibits116: Data Table on Canada - Year-over-year growth 2024-2029 (%); Exhibits117: Chart on UK - Market size and forecast 2024-2029 ($ million); Exhibits118: Data Table on UK - Market size and forecast 2024-2029 ($ million); Exhibits119: Chart on UK - Year-over-year growth 2024-2029 (%); Exhibits120: Data Table on UK - Year-over-year growth 2024-2029 (%); Exhibits121: Chart on Germany - Market size and forecast 2024-2029 ($ million); Exhibits122: Data Table on Germany - Market size and forecast 2024-2029 ($ million); Exhibits123: Chart on Germany - Year-over-year growth 2024-2029 (%); Exhibits124: Data Table on Germany - Year-over-year growth 2024-2029 (%); Exhibits125: Chart on China - Market size and forecast 2024-2029 ($ million); Exhibits126: Data Table on China - Market size and forecast 2024-2029 ($ million); Exhibits127: Chart on China - Year-over-year growth 2024-2029 (%); Exhibits128: Data Table on China - Year-over-year growth 2024-2029 (%); Exhibits129: Chart on France - Market size and forecast 2024-2029 ($ million); Exhibits130: Data Table on France - Market size and forecast 2024-2029 ($ million); Exhibits131: Chart on France - Year-over-year growth 2024-2029 (%); Exhibits132: Data Table on France - Year-over-year growth 2024-2029 (%); Exhibits133: Chart on Italy - Market size and forecast 2024-2029 ($ million); Exhibits134: Data Table on Italy - Market size and forecast 2024-2029 ($ million); Exhibits135: Chart on Italy - Year-over-year growth 2024-2029 (%); Exhibits136: Data Table on Italy - Year-over-year growth 2024-2029 (%); Exhibits137: Chart on Japan - Market size and forecast 2024-2029 ($ million); Exhibits138: Data Table on Japan - Market size and forecast 2024-2029 ($ million); Exhibits139: Chart on Japan - Year-over-year growth 2024-2029 (%); Exhibits140: Data Table on Japan - Year-over-year growth 2024-2029 (%); Exhibits141: Chart on India - Market size and forecast 2024-2029 ($ million); Exhibits142: Data Table on India - Market size and forecast 2024-2029 ($ million); Exhibits143: Chart on India - Year-over-year growth 2024-2029 (%); Exhibits144: Data Table on India - Year-over-year growth 2024-2029 (%); Exhibits145: Chart on The Netherlands - Market size and forecast 2024-2029 ($ million); Exhibits146: Data Table on The Netherlands - Market size and forecast 2024-2029 ($ million); Exhibits147: Chart on The Netherlands - Year-over-year growth 2024-2029 (%); Exhibits148: Data Table on The Netherlands - Year-over-year growth 2024-2029 (%); Exhibits149: Market opportunity By Geographical Landscape ($ million); Exhibits150: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits151: Impact of drivers and challenges in 2024 and 2029; Exhibits152: Overview on criticality of inputs and factors of differentiation; Exhibits153: Overview on factors of disruption; Exhibits154: Impact of key risks on business; Exhibits155: Companies covered; Exhibits156: Company ranking index; Exhibits157: Matrix on companies position and classification; Exhibits158: Adaptive Biotechnologies Corp. - Overview; Exhibits159: Adaptive Biotechnologies Corp. - Product / Service; Exhibits160: Adaptive Biotechnologies Corp. - Key offerings; Exhibits161: SWOT; Exhibits162: Almirall SA - Overview; Exhibits163: Almirall SA - Product / Service; Exhibits164: Almirall SA - Key offerings; Exhibits165: SWOT; Exhibits166: Amgen Inc. - Overview; Exhibits167: Amgen Inc. - Product / Service; Exhibits168: Amgen Inc. - Key news; Exhibits169: Amgen Inc. - Key offerings; Exhibits170: SWOT; Exhibits171: AMYRA Biotech AG - Overview; Exhibits172: AMYRA Biotech AG - Product / Service; Exhibits173: AMYRA Biotech AG - Key offerings; Exhibits174: SWOT; Exhibits175: BioLineRx Ltd. - Overview; Exhibits176: BioLineRx Ltd. - Product / Service; Exhibits177: BioLineRx Ltd. - Key offerings; Exhibits178: SWOT; Exhibits179: Bristol Myers Squibb Co. - Overview; Exhibits180: Bristol Myers Squibb Co. - Product / Service; Exhibits181: Bristol Myers Squibb Co. - Key news; Exhibits182: Bristol Myers Squibb Co. - Key offerings; Exhibits183: SWOT; Exhibits184: Calypso Biotech BV - Overview; Exhibits185: Calypso Biotech BV - Product / Service; Exhibits186: Calypso Biotech BV - Key offerings; Exhibits187: SWOT; Exhibits188: GlaxoSmithKline Plc - Overview; Exhibits189: GlaxoSmithKline Plc - Business segments; Exhibits190: GlaxoSmithKline Plc - Key news; Exhibits191: GlaxoSmithKline Plc - Key offerings; Exhibits192: GlaxoSmithKline Plc - Segment focus; Exhibits193: SWOT; Exhibits194: Glenmark Pharmaceuticals Ltd. - Overview; Exhibits195: Glenmark Pharmaceuticals Ltd. - Product / Service; Exhibits196: Glenmark Pharmaceuticals Ltd. - Key offerings; Exhibits197: SWOT; Exhibits198: ImmunogenX Inc. - Overview; Exhibits199: ImmunogenX Inc. - Product / Service; Exhibits200: ImmunogenX Inc. - Key offerings; Exhibits201: SWOT; Exhibits202: Johnson and Johnson Services Inc. - Overview; Exhibits203: Johnson and Johnson Services Inc. - Business segments; Exhibits204: Johnson and Johnson Services Inc. - Key news; Exhibits205: Johnson and Johnson Services Inc. - Key offerings; Exhibits206: Johnson and Johnson Services Inc. - Segment focus; Exhibits207: SWOT; Exhibits208: Precigen Inc. - Overview; Exhibits209: Precigen Inc. - Product / Service; Exhibits210: Precigen Inc. - Key offerings; Exhibits211: SWOT; Exhibits212: Sanofi SA - Overview; Exhibits213: Sanofi SA - Business segments; Exhibits214: Sanofi SA - Key news; Exhibits215: Sanofi SA - Key offerings; Exhibits216: Sanofi SA - Segment focus; Exhibits217: SWOT; Exhibits218: Takeda Pharmaceutical Co. Ltd. - Overview; Exhibits219: Takeda Pharmaceutical Co. Ltd. - Product / Service; Exhibits220: Takeda Pharmaceutical Co. Ltd. - Key news; Exhibits221: Takeda Pharmaceutical Co. Ltd. - Key offerings; Exhibits222: SWOT; Exhibits223: Teva Pharmaceutical Industries Ltd. - Overview; Exhibits224: Teva Pharmaceutical Industries Ltd. - Business segments; Exhibits225: Teva Pharmaceutical Industries Ltd. - Key news; Exhibits226: Teva Pharmaceutical Industries Ltd. - Key offerings; Exhibits227: Teva P